查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386203

甲型肝炎疫苗市場報告：2030 年趨勢、預測與競爭分析

Hepatitis A Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

甲型肝炎疫苗的趨勢和預測

預計到 2030 年，全球甲型肝炎疫苗市場將達到 10 億美元，2024 年至 2030 年複合年成長率為 3.6%。該市場的主要促進因素是人們對疫苗接種重要性的認知不斷提高、政府遏制甲型肝炎傳播的支持措施以及新興國家醫療基礎設施的改善。全球甲型肝炎疫苗市場前景廣闊，政府和私人市場都有商機。

甲型肝炎疫苗市場洞察

Lucintel 預測，減毒活病毒疫苗預計將在預測期內出現高速成長，因為它們被廣泛用於預防自然感染並建立強大且持久的免疫反應。

在這個市場中，政府機構預計在預測期內將呈現高成長。

由於人口持續成長和甲型肝炎感染數量增加，預計亞太地區在預測期內將經歷最高的成長。

市場規模/估計：以金額計算的甲型肝炎疫苗市場規模估計（10 億美元）。

趨勢和預測分析：各個區隔市場和地區的市場趨勢（2018-2023）和預測（2024-2030）。

市場區隔分析：依類型、應用和地區依金額估算的甲型肝炎疫苗市場規模（十億美元）

區域分析：北美、歐洲、亞太地區和世界其他地區甲型肝炎疫苗市場的區域區隔。

成長機會：甲型肝炎疫苗市場依類型、應用和地區進行的成長機會分析。

策略分析：甲肝疫苗市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球甲型肝炎疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球甲型肝炎疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 全球甲型肝炎疫苗市場（依類型）
    • 去活化疫苗
    • 減毒活病毒疫苗
  • 全球甲型肝炎疫苗市場依應用
    • 政府機關
    • 私人的
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球甲型肝炎疫苗市場區域分佈
  • 北美甲型肝炎疫苗市場
  • 歐洲甲型肝炎疫苗市場
  • 亞太地區甲型肝炎疫苗市場
  • 其他地區甲肝疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球甲型肝炎疫苗市場成長機會（依類型）
    • 全球甲型肝炎疫苗市場成長機會（依應用）
    • 全球甲型肝炎疫苗市場成長機會（依地區）
  • 全球甲型肝炎疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球甲型肝炎疫苗市場產能擴張
    • 全球甲型肝炎疫苗市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • GlaxoSmithKline
  • Merck & Co
  • Sanofi
  • Sinovac
  • Zhejiang Pukang
  • Changchun Institute of Biological
  • KM Biologics
  • IMBCA
  • ChangSheng
  • Convac
簡介目錄

Hepatitis A Vaccine Trends and Forecast

The future of the global hepatitis A vaccine market looks promising with opportunities in the government institution and private sector markets. The global hepatitis A vaccine market is expected to reach an estimated $1.0 billion by 2030 with a CAGR of 3.6% from 2024 to 2030. The major drivers for this market are rising awareness about the importance of immunization, supportive government initiatives to control the spread of hepatitis A, and growing healthcare infrastructure in developing countries.

A more than 150-page report is developed to help in your business decisions.

Hepatitis A Vaccine by Segment

The study includes a forecast for the global hepatitis A vaccine by type, application, and region.

Hepatitis A Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Inactivated Vaccine
  • Live Attenuated Vaccine

Hepatitis A Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Government Institution
  • Private Sector
  • Others

Hepatitis A Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Hepatitis A Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hepatitis A vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hepatitis A vaccine companies profiled in this report include-

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Sinovac
  • Zhejiang Pukang
  • Changchun Institute Of Biological
  • KM Biologics
  • IMBCA
  • Changsheng
  • Convac

Hepatitis A Vaccine Market Insights

Lucintel forecasts that live attenuated vaccine is expected to witness higher growth over the forecast period due to its widespread usage to prevent natural infection and build a strong and long-lasting immune response.

Within this market, government institution is expected to witness higher growth over the forecast period.

APAC is expected to witness highest growth over the forecast period due to continous growth of population base and rising number of hepatitis A infection affected population in the region.

Features of the Global Hepatitis A Vaccine Market

Market Size Estimates: Hepatitis a vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Hepatitis a vaccine market size by type, application, and region in terms of value ($B).

Regional Analysis: Hepatitis a vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the hepatitis A vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hepatitis A vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the hepatitis A vaccine market size?

Answer: The global hepatitis A vaccine market is expected to reach an estimated $1.0 billion by 2030.

Q.2 What is the growth forecast for hepatitis A vaccine market?

Answer: The global hepatitis A vaccine market is expected to grow with a CAGR of 3.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the hepatitis A vaccine market?

Answer: The major drivers for this market are rising awareness about the importance of immunization, supportive government initiatives to control the spread of hepatitis A, and growing healthcare infrastructure in developing countries.

Q4. What are the major segments for hepatitis A vaccine market?

Answer: The future of the hepatitis A vaccine market looks promising with opportunities in the government institution and private sector markets.

Q5. Who are the key hepatitis A vaccine market companies?

Answer: Some of the key hepatitis A vaccine companies are as follows:

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Sinovac
  • Zhejiang Pukang
  • Changchun Institute Of Biological
  • KM Biologics
  • IMBCA
  • Changsheng
  • Convac

Q6. Which hepatitis A vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that live attenuated vaccine is expected to witness higher growth over the forecast period due to its widespread usage to prevent natural infection and build a strong and long-lasting immune response.

Q7. In hepatitis A vaccine market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to continous growth of population base and rising number of hepatitis A infection affected population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the hepatitis A vaccine market by type (inactivated vaccine and live attenuated vaccine), application (government institution, private sector, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Hepatitis A Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Hepatitis A Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Hepatitis A Vaccine Market by Type
    • 3.3.1: Inactivated vaccine
    • 3.3.2: Live Attenuated Vaccine
  • 3.4: Global Hepatitis A Vaccine Market by Application
    • 3.4.1: Government Institution
    • 3.4.2: Private Sector
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Hepatitis A Vaccine Market by Region
  • 4.2: North American Hepatitis A Vaccine Market
    • 4.2.2: North American Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others
  • 4.3: European Hepatitis A Vaccine Market
    • 4.3.1: European Hepatitis A Vaccine Market by Type: Inactivated vaccine and Live Attenuated Vaccine
    • 4.3.2: European Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others
  • 4.4: APAC Hepatitis A Vaccine Market
    • 4.4.1: APAC Hepatitis A Vaccine Market by Type: Inactivated vaccine and Live Attenuated Vaccine
    • 4.4.2: APAC Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others
  • 4.5: ROW Hepatitis A Vaccine Market
    • 4.5.1: ROW Hepatitis A Vaccine Market by Type: Inactivated vaccine and Live Attenuated Vaccine
    • 4.5.2: ROW Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Hepatitis A Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Hepatitis A Vaccine Market by Application
    • 6.1.3: Growth Opportunities for the Global Hepatitis A Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Hepatitis A Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Hepatitis A Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hepatitis A Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GlaxoSmithKline
  • 7.2: Merck & Co
  • 7.3: Sanofi
  • 7.4: Sinovac
  • 7.5: Zhejiang Pukang
  • 7.6: Changchun Institute of Biological
  • 7.7: KM Biologics
  • 7.8: IMBCA
  • 7.9: ChangSheng
  • 7.10: Convac